Oxford Biomedica plc (OTCMKTS:OXBDF) Sees Large Increase in Short Interest

Oxford Biomedica plc (OTCMKTS:OXBDF) saw a significant growth in short interest in March. As of March 15th, there was short interest totalling 134,600 shares, a growth of 71.9% from the February 28th total of 78,300 shares. Based on an average trading volume of 2,000 shares, the short-interest ratio is presently 67.3 days. Approximately 0.1% of the company’s shares are short sold.

Oxford Biomedica Price Performance

Shares of Oxford Biomedica stock opened at $3.88 on Monday. Oxford Biomedica has a twelve month low of $2.44 and a twelve month high of $5.68. The company has a quick ratio of 2.07, a current ratio of 2.35 and a debt-to-equity ratio of 1.48. The company has a fifty day moving average price of $4.49 and a 200 day moving average price of $4.92.

About Oxford Biomedica

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.